Explore All 3111 Add-on Acquisition Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | October 14, 2011 |
| Target | Cephalon |
| Sector | Life Science |
| Buyer(s) | Teva Pharmaceutical Industries |
| Deal Type | Add-on Acquisition |
| Deal Value | 6.8B USD |
| Advisor(s) | BofA Securities Deutsche Bank Corporate & Investment Banking (Financial) Skadden, Arps, Slate, Meagher & Flom (Legal) |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1901 |
| Sector | Life Science |
| Employees | 37,000 |
| Revenue | 16.5B USD (2024) |
Teva Pharmaceutical Industries is a provider of pharmaceutical products, committed to increasing access to high-quality healthcare by developing, producing, and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Teva Pharmaceutical Industries was founded in 1901 and is based in Tel Aviv, Israel.
| Deal Context for Buyer | # |
|---|---|
| Overall | 14 of 23 |
| Sector: Life Science | 13 of 20 |
| Type: Add-on Acquisition | 12 of 19 |
| State: Pennsylvania | 1 of 2 |
| Country: United States | 7 of 15 |
| Year: 2011 | 2 of 2 |
| Size (of disclosed) | 4 of 14 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-01-26 |
Corporación Infarmasa SA
Lima, Peru Corporación Infarmasa SA manufactures and markets branded and unbranded generic drugs, primarily corticosteroids, antihistamines, analgesics and antibiotics, and has of over 600 registered products, of which over 500 are currently marketed. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-06-17 |
MicroDose Therapeutx
Monmouth Junction, New Jersey, United States MicroDose Therapeutx is a private pharmaceutical company focused on developing proprietary pulmonary and oral products that address large unmet market opportunities, and on dry powder inhalation and combination oral dosage delivery platforms. |
Buy | $40M |
